RxDoctor Payments Data

Mark Baptiste, MD

Psychiatry · Camden, NJNPI 1396271938

Payments from drug & device makers

$1,311in general payments, 2019–2025

Across 78 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$352
  • Otsuka America Pharmaceutical, Inc.$236
  • Neurocrine Biosciences, Inc.$191
  • AbbVie$141
  • Lundbeck LLC$120
  • Johnson & Johnson$85
  • plus $188 from 3 others

What the payments were for

  • Food & beverage$1,311100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,311 in reported general payments places this provider in the 75th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$13,647
Medicare patients
49
Services billed
106

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate90$222,567
IngrezzaValbenazine Tosylate15$132,531
AustedoDeutetrabenazine14$126,745
Austedo XrDeutetrabenazine12$98,254
Abilify MaintenaAripiprazole15$39,760
Aripiprazole111$8,758
Lurasidone Hcl28$8,054
Divalproex Sodium ErDivalproex Sodium46$5,214
VyvanseLisdexamfetamine Dimesylate11$4,725
Quetiapine Fumarate184$3,019
Chlorpromazine Hcl11$2,981
Duloxetine Hcl98$2,972
Risperidone174$2,907
Divalproex Sodium96$2,843
Oxcarbazepine60$2,705

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo, Austedo Xr$352$224,99926 claims
Johnson & JohnsonInvega Sustenna$85$222,56790 claims
Neurocrine Biosciences, Inc.Ingrezza$191$132,53115 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$236$39,76015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Camden

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →